U D Gupta

747 total citations
27 papers, 481 citations indexed

About

U D Gupta is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, U D Gupta has authored 27 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 12 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in U D Gupta's work include Mycobacterium research and diagnosis (11 papers), Leprosy Research and Treatment (10 papers) and Tuberculosis Research and Epidemiology (9 papers). U D Gupta is often cited by papers focused on Mycobacterium research and diagnosis (11 papers), Leprosy Research and Treatment (10 papers) and Tuberculosis Research and Epidemiology (9 papers). U D Gupta collaborates with scholars based in India, Sweden and Belgium. U D Gupta's co-authors include Pushpa Gupta, Maria Lerm, Sanjaya Kumar Sahu, Manikuntala Kundu, Rudi Beyaert, Ranjeet Kumar, Kuladip Jana, Manish Kumar, Joyoti Basu and Johanna Raffetseder and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Immunology.

In The Last Decade

U D Gupta

27 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U D Gupta India 12 205 200 157 144 133 27 481
Peter M. Broglie United States 8 154 0.8× 370 1.9× 62 0.4× 82 0.6× 263 2.0× 8 619
Sarah Wachtel United States 7 144 0.7× 383 1.9× 87 0.6× 53 0.4× 221 1.7× 8 603
Prashant Rai United States 10 60 0.3× 213 1.1× 187 1.2× 50 0.3× 241 1.8× 19 543
Noemi Cifani Italy 13 112 0.5× 178 0.9× 111 0.7× 30 0.2× 106 0.8× 21 602
Jenny E. Emerson United Kingdom 7 352 1.7× 133 0.7× 159 1.0× 24 0.2× 52 0.4× 7 502
Yongsheng Ma United States 8 322 1.6× 206 1.0× 96 0.6× 20 0.1× 76 0.6× 10 578
Martine Soell France 11 62 0.3× 163 0.8× 81 0.5× 135 0.9× 193 1.5× 15 723
Jacqueline Carrère France 12 414 2.0× 136 0.7× 234 1.5× 24 0.2× 45 0.3× 19 749
Uma Devi Ranganathan India 15 357 1.7× 169 0.8× 265 1.7× 18 0.1× 181 1.4× 39 595
Marc A. Keen United States 10 528 2.6× 149 0.7× 411 2.6× 37 0.3× 452 3.4× 10 802

Countries citing papers authored by U D Gupta

Since Specialization
Citations

This map shows the geographic impact of U D Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U D Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U D Gupta more than expected).

Fields of papers citing papers by U D Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U D Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U D Gupta. The network helps show where U D Gupta may publish in the future.

Co-authorship network of co-authors of U D Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of U D Gupta. A scholar is included among the top collaborators of U D Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U D Gupta. U D Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Christina J., et al.. (2024). Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy. Cancers. 16(22). 3810–3810. 13 indexed citations
2.
Lavania, Mallika, et al.. (2022). Potential approaches for the diagnosis and treatment of drug-resistant leprosy. SHILAP Revista de lepidopterología. 1(1). 21–25. 2 indexed citations
3.
Goel, Manish, Uma Shankar, Amit Kumar, et al.. (2020). An Aptamer Linked Immobilized Sorbent Assay (ALISA) to Detect Circulatory IFN-α, an Inflammatory Protein among Tuberculosis Patients. ACS Combinatorial Science. 22(11). 656–666. 19 indexed citations
4.
Gupta, U D, Mohan Natrajan, Devendra Singh Chauhan, et al.. (2018). Potential of adjunctive Mycobacterium w (MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis. Indian Journal of Tuberculosis. 65(4). 335–344. 11 indexed citations
5.
Owais, Mohammad, Jagdeep Kaur, Gurpreet Singh, et al.. (2016). TLR Agonist Augments Prophylactic Potential of Acid Inducible Antigen Rv3203 against Mycobacterium tuberculosis H37Rv in Experimental Animals. PLoS ONE. 11(3). e0152240–e0152240. 8 indexed citations
6.
Kumar, Manish, Sanjaya Kumar Sahu, Ranjeet Kumar, et al.. (2015). MicroRNA let-7 Modulates the Immune Response to Mycobacterium tuberculosis Infection via Control of A20, an Inhibitor of the NF-κB Pathway. Cell Host & Microbe. 17(3). 345–356. 217 indexed citations
7.
Singh, Gurpreet, et al.. (2015). Characterization of a novel esterase Rv1497 of Mycobacterium tuberculosis H37Rv demonstrating β-lactamase activity. Enzyme and Microbial Technology. 82. 180–190. 27 indexed citations
8.
Tufail, Saba, Khan Farheen Badrealam, Mohammad Asif Sherwani, U D Gupta, & Mohammad Owais. (2013). Tissue Specific Heterogeneity in Effector Immune Cell Response. Frontiers in Immunology. 4. 254–254. 11 indexed citations
9.
Singh, Gurpreet, et al.. (2013). Characterization of an acid inducible lipase Rv3203 from Mycobacterium tuberculosis H37Rv. Molecular Biology Reports. 41(1). 285–296. 27 indexed citations
10.
Katoch, K, et al.. (2012). Chemotherapy trials in MB leprosy using conventional and newer drugs pefloxacin and minocycline.. PubMed. 66(1). 18–25. 4 indexed citations
11.
Jain, Ruchi, Bappaditya Dey, Aparna Khera, et al.. (2011). Over-expression of superoxide dismutase obliterates the protective effect of BCG against tuberculosis by modulating innate and adaptive immune responses. Vaccine. 29(45). 8118–8125. 17 indexed citations
12.
Gupta, U D, K Katoch, & V M Katoch. (2010). Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.. PubMed. 81(3). 131–4. 10 indexed citations
13.
Katoch, K, et al.. (2010). Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.. PubMed. 80(4). 331–44. 8 indexed citations
15.
Katoch, Kiran, et al.. (2004). 10–12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy. Vaccine. 22(27-28). 3649–3657. 19 indexed citations
16.
Nanda, Sanju, et al.. (2004). Topical phenytoin suspension and normal saline in the treatment of leprosy trophic ulcers: a randomized, double‐blind, comparative study. Journal of Dermatological Treatment. 15(5). 321–327. 22 indexed citations
17.
Gupta, U D, et al.. (2001). Assessment of viability by normal mouse foot-pad and bacillary ATP bioluminescence assay in multibacillary cases treated with an MDT regimen using conventional as well as newer drugs like minocycline and ofloxacin.. PubMed. 72(4). 437–42. 2 indexed citations
18.
Gulati, Ruchi, et al.. (1997). Comparative bioavailability of two brands of cyclosporin. Indian Journal of Pharmacology. 29(2). 135. 4 indexed citations
19.
Gupta, U D, et al.. (1973). Microbial flora of the vagina with special reference to anaerobic bacteria and mycoplasma.. PubMed. 61(11). 1600–3. 5 indexed citations
20.
Gupta, U D, et al.. (1973). Isolation of T-strain mycoplasma from the male genitourinary tract: voided urine versus the urethral discharge.. PubMed. 61(12). 1771–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026